PMS2 and adenocarcinoma: Immunohistochemical patterns differ between medullary carcinoma and other poorly differentiated adenocarcinomas.8) Medullary carcinoma often shows loss of MLH1 and PMS2, whereas poorly differentiated adenocarcinomas typically do not.